{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:29:24Z","timestamp":1786476564487,"version":"build-2736575974"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigacion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neurobiolaging.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:54:50Z","timestamp":1781798090000},"page":"76-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Decreased awareness of cognitive decline is associated with multimodal Alzheimer\u2019s disease biomarkers in cognitively unimpaired individuals"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1150-2619","authenticated-orcid":false,"given":"David","family":"L\u00f3pez-Martos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5210-9230","authenticated-orcid":false,"given":"Gemma","family":"Salvad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Cacciaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Shekari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Gonz\u00e1lez-Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Horta-Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4961-8077","authenticated-orcid":false,"given":"Helena","family":"Palma-Gudiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mil\u00e0-Alom\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brugulat-Serrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Minguillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Tonietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-7374","authenticated-orcid":false,"given":"Edilio","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7571-8912","authenticated-orcid":false,"given":"Gregory","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9050-3282","authenticated-orcid":false,"given":"Clara","family":"Quijano-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendlyn","family":"Kollmorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-800X","authenticated-orcid":false,"given":"Gonzalo","family":"S\u00e1nchez-Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4730-5341","authenticated-orcid":false,"given":"Oriol","family":"Grau-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.14283\/jpad.2024.125","article-title":"Longitudinal trajectories of the cognitive function index in the A4 Study","volume":"11","author":"Amariglio","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s42003-024-07076-7","article-title":"The unique role of anosognosia in the clinical progression of Alzheimer\u2019s disease: a disorder-network perspective","volume":"7","author":"Andrade","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.697234","article-title":"Awareness of Cognitive Decline in Patients With Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"13","author":"Cacciamani","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3233\/JAD-201246","article-title":"Structural Gray and White Matter Correlates of Awareness in Alzheimer\u2019s Disease","volume":"81","author":"Bertrand","year":"2021","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib6","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0028-3932(01)00055-0","article-title":"Clinical validity of the \u2018mini-mental state\u2019 for Spanish speaking communities","volume":"39","author":"Blesa","year":"2001","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib7","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer\u2019s disease: Evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-024-00497-9","article-title":"Multi-modal Neuroimaging Phenotyping of Mnemonic Anosognosia in the Aging Brain","volume":"4","author":"Bueichek\u00fa","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib9","article-title":"The CSF p-tau\/\u03b2-amyloid 42 ratio correlates with brain structure and fibrillary \u03b2-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer\u2019s disease","volume":"7","author":"Cacciaglia","year":"2025","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.811739","article-title":"Differential Patterns of Domain-Specific Cognitive Complaints and Awareness Across the Alzheimer\u2019s Disease Spectrum","volume":"14","author":"Cacciamani","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-020-00700-8","article-title":"Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD","volume":"12","author":"Cacciamani","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib12","first-page":"753","article-title":"Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer\u2019s Disease","volume":"59","author":"Cacciamani","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13905","article-title":"Subjective cognitive decline: Memory complaints, cognitive awareness, and metacognition","author":"Cappa","year":"2024","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jalz.2013.01.003","article-title":"Subjective cognitive decline: Self and informant comparisons","volume":"10","author":"Caselli","year":"2014","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/arclin\/acaa104","article-title":"Development of standardized regression-based formulas to assess meaningful cognitive change in early Parkinson\u2019s disease","volume":"36","author":"Combs","year":"2021","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib16","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0010-9452(08)70697-X","article-title":"Objective Metamemory Testing Captures Awareness of Deficit in Alzheimer\u2019s Disease","volume":"43","author":"Cosentino","year":"2007","journal-title":"Cortex"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12883-020-01719-y","article-title":"Standardized regression-based clinical change score cutoffs for normal pressure hydrocephalus","volume":"20","author":"Davis","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical Alzheimer cognitive composite: Measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib19","article-title":"The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries","volume":"12","author":"Dubbelman","year":"2020","journal-title":"Alzheimer\u2019S. Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/arclin\/acr120","article-title":"Current topics in science and practice evidence-based indicators of neuropsychological change in the individual patient: Relevant concepts and methods","volume":"27","author":"Duff","year":"2012","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib22","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1017\/S135561771400068X","article-title":"Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment","volume":"20","author":"Edmonds","year":"2014","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3233\/JAD-150986","article-title":"\u201cMissed\u201d Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria","volume":"52","author":"Edmonds","year":"2016","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1017\/S1355617718000486","article-title":"Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment","volume":"24","author":"Edmonds","year":"2018","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib25","series-title":"in: The Oxford Handbook of Metamemory","first-page":"456","article-title":"Anosognosia and metacognition in Alzheimer\u2019s disease: Insights from experimental psychology","author":"Ernst","year":"2016"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib26","doi-asserted-by":"crossref","first-page":"E1512","DOI":"10.1212\/WNL.0000000000200137","article-title":"Association of Emerging \u03b2-Amyloid and Tau Pathology with Early Cognitive Changes in Clinically Normal Older Adults","volume":"98","author":"Farrell","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib27","article-title":"Dementia prevention in memory clinics: recommendations from the European task force for brain health services","volume":"26","author":"Frisoni","year":"2023","journal-title":"Lancet Reg. Health - Eur."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib28","first-page":"12","article-title":"The meta-memory ratio: A new cohort-independent way to measure cognitive awareness in asymptomatic individuals at risk for Alzheimer\u2019s disease","author":"Gagliardi","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JAD-151175","article-title":"The Memory Binding Test: Development of Two Alternate Forms into Spanish and Catalan","volume":"52","author":"Gramunt","year":"2016","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of Amyloid and Tau with Cognition in Preclinical Alzheimer Disease: A Longitudinal Study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.25649","article-title":"Evolution of anosognosia in alzheimer\u2019s disease and its relationship to amyloid","volume":"87","author":"Hanseeuw","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib32","article-title":"Understanding Alzheimer\u2019s disease as a disorder of consciousness","volume":"7","author":"Huntley","year":"2021","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jamaneurol.2025.2974","article-title":"Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease","volume":"82","author":"Insel","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib35","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/brain\/awy059","article-title":"Longitudinal tau PET in ageing and Alzheimer\u2019s disease","volume":"141","author":"Jack","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/JGP.0b013e31819431d5","article-title":"Quantification of five neuropsychological approaches to defining mild cognitive impairment","volume":"17","author":"Jak","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib38","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-014-0539-z","article-title":"Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer\u2019s disease","author":"Jessen","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib39","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimer\u2019S. & Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib40","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/alz.12163","article-title":"Prediction of dementia of Alzheimer type by different types of subjective cognitive decline","volume":"16","author":"Jessen","year":"2020","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib41","article-title":"The characterisation of subjective cognitive decline","author":"Jessen","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib42","first-page":"26","article-title":"Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire","volume":"8","author":"Jutten","year":"2017","journal-title":"Alzheimer\u2019S. Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1394460","article-title":"Awareness of episodic memory and meta-cognitive profiles: associations with cerebrospinal fluid biomarkers at the preclinical stage of the Alzheimer\u2019s continuum","volume":"16","author":"L\u00f3pez-Martos","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib44","doi-asserted-by":"crossref","DOI":"10.1037\/neu0001013","article-title":"Robust Longitudinal Neuropsychological Norms in Spanish Individuals With Nonpathological Alzheimer\u2019s Disease Biomarkers","author":"L\u00f3pez-Martos","year":"2025","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib45","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214308","article-title":"Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease","volume":"105","author":"L\u00f3pez-Martos","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2026.100612","article-title":"Multimodal biomarker characterization of amnestic objective subtle cognitive decline in aging and preclinical Alzheimer\u2019s disease","volume":"13","author":"L\u00f3pez-Martos","year":"2026","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.yebeh.2005.10.004","article-title":"Determining empirically based self-reported cognitive change: Development of reliable change indices and standardized regression-based change norms for the multiple abilities self-report questionnaire in an epilepsy sample","volume":"8","author":"Martin","year":"2006","journal-title":"Epilepsy & Behav."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib48","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaneurol.2019.2214","article-title":"Staging \u03b2 -Amyloid Pathology with Amyloid Positron Emission Tomography","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib49","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib50","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer\u2019s disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2387","article-title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer\u2019s disease","volume":"6","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s44321-025-00348-7","article-title":"Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and \u03b2-amyloid","volume":"18","author":"Mattsson-Carlgren","year":"2026","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib54","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12131","article-title":"Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum","volume":"16","author":"Mil\u00e0-Alom\u00e0","year":"2020","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.9964","article-title":"Measurement of Dimensions of Self-awareness of Memory Function and Their Association With Clinical Progression in Cognitively Normal Older Adults","volume":"6","author":"Mimmack","year":"2023","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ageing\/afn147","article-title":"Is it time to separate subjective cognitive complaints from the diagnosis of mild cognitive impairment?","volume":"37","author":"Mitchell","year":"2008","journal-title":"Age Ageing"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1017\/S1355617713001276","article-title":"On the Relation among Mood, Apathy, and Anosognosia in Alzheimer\u2019s Disease","volume":"20","author":"Mograbi","year":"2014","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.concog.2009.07.005","article-title":"Anosognosia in Alzheimer\u2019s disease - The petrified self","author":"Mograbi","year":"2009","journal-title":"Conscious. Cogn."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib59","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-021-01155-6","article-title":"Self-awareness in dementia: a taxonomy of processes, overview of findings, and integrative framework","author":"Mograbi","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.trci.2016.02.003","article-title":"The ALFA project: a research platform to identify early pathophysiological features of Alzheimer\u2019s disease","volume":"2","author":"Molinuevo","year":"2016","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2016.09.012","article-title":"Implementation of subjective cognitive decline criteria in research studies","author":"Molinuevo","year":"2017","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib62","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR)","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib63","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.cortex.2012.09.006","article-title":"Anosognosia, autobiographical memory and self knowledge in Alzheimer\u2019s disease","volume":"49","author":"Morris","year":"2013","journal-title":"Cortex"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.806432","article-title":"Longitudinal trajectories of participant- and study partner-rated cognitive decline, in relation to alzheimer\u2019s disease biomarkers and mood symptoms","volume":"13","author":"Munro","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib65","article-title":"The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations","volume":"8","author":"Nosheny","year":"2022","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib66","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","article-title":"Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline","volume":"28","author":"Ossenkoppele","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s43587-025-00835-z","article-title":"Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials","author":"Ossenkoppele","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib68","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamaneurol.2022.2442","article-title":"Spatial extent of Amyloid-\u03b2 levels and associations with Tau-PET and cognition","volume":"79","author":"Ozlen","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib69","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","article-title":"Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease","volume":"85","author":"Palmqvist","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01150-x","article-title":"Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity","volume":"8","author":"Palmqvist","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03622-w","article-title":"Plasma phospho-tau217 for Alzheimer\u2019s disease diagnosis in primary and secondary care using a fully automated platform","author":"Palmqvist","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib72","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.trci.2017.10.004","article-title":"Optimizing the preclinical Alzheimer\u2019s cognitive composite with semantic processing: The PACC5","volume":"3","author":"Papp","year":"2017","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib73","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/arclin\/acp042","article-title":"Spanish multicenter normative studies (NEURONORMA project): norms for verbal fluency tests","volume":"24","author":"Pe\u00f1a-Casanova","year":"2009","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib74","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/arclin\/acp041","article-title":"Spanish multicenter normative studies (NEURONORMA project): Norms for the rey-osterrieth complex figure (copy and memory), and free and cued selective reminding test","volume":"24","author":"Pe\u00f1a-Casanova","year":"2009","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib75","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.24462","article-title":"Anosognosia in Alzheimer disease: Disconnection between memory and self-related brain networks","volume":"78","author":"Perrotin","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib76","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/alz.12748","article-title":"The AHEAD 3\u201345 Study: Design of a prevention trial for Alzheimer\u2019s disease","volume":"19","author":"Rafii","year":"2023","journal-title":"Alzheimer\u2019S. & Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib77","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3233\/JAD-132027","article-title":"The subjective cognitive decline questionnaire (SCD-Q): A validation study","volume":"41","author":"Rami","year":"2014","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JAD-180378","article-title":"Distinct cognitive and brain morphological features in healthy subjects unaware of informant-reported cognitive decline","volume":"65","author":"S\u00e1nchez-Benavides","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib79","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2025.3217","article-title":"Plasma phosphorylated tau 217 to identify preclinical Alzheimer disease","volume":"82","author":"Salvad\u00f3","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/01688639008400962","article-title":"Toward a cognitive neuropsychology of awareness: Implicit knowledge and anosognosia","volume":"12","author":"Schacter","year":"1990","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib81","series-title":"in: The Neuropsychology of Consciousness","first-page":"179","article-title":"Consciousness and Awareness in Memory and Amnesia: Critical Issues","author":"Schacter","year":"1992"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib82","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1002\/alz.13883","article-title":"Stress testing the centiloid: precision and variability of PET quantification of amyloid pathology","volume":"20","author":"Shekari","year":"2024","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib83","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000346277","article-title":"Validation of the amsterdam IADL questionnaire\u00a9, a new tool to measure instrumental activities of daily living in dementia","volume":"41","author":"Sikkes","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib84","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s40120-025-00798-8","article-title":"Clinical performance of the elecsys CSF pTau181\/A\u03b242 ratio for concordance with Tau-PET in two independent cohorts","volume":"14","author":"Smith","year":"2025","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib85","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","article-title":"Amyloid deposition is associated with impaired default network function in older persons without dementia","volume":"63","author":"Sperling","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib86","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of Solanezumab in Preclinical Alzheimer\u2019s Disease","volume":"389","author":"Sperling","year":"2023","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib87","doi-asserted-by":"crossref","first-page":"802","DOI":"10.14283\/jpad.2024.122","article-title":"Amyloid and Tau prediction of cognitive and functional decline in unimpaired older individuals: longitudinal data from the A4 and LEARN Studies","volume":"11","author":"Sperling","year":"2024","journal-title":"J. Prev. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib88","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cortex.2014.07.019","article-title":"Anosognosia in Alzheimer\u2019s disease: diagnosis, frequency, mechanism and clinical correlates","volume":"61","author":"Starkstein","year":"2014","journal-title":"Cortex"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib89","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jnnp.2005.085373","article-title":"A diagnostic formulation for anosognosia in Alzheimer\u2019s disease","volume":"77","author":"Starkstein","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib90","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012921","article-title":"Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in A\u03b2 pathology are detected","volume":"12","author":"Su\u00e1rez-Calvet","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib91","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1371\/journal.pbio.0040128","article-title":"Neocortical connectivity during episodic memory formation","volume":"4","author":"Summerfield","year":"2006","journal-title":"PLoS. Biol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib92","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-017-0734-1","article-title":"Integrating the Constructs of Anosognosia and Metacognition: a Review of Recent Findings in Dementia","author":"Sunderaraman","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib93","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.1212\/WNL.0000000000005120","article-title":"Anosognosia predicts default mode network hypometabolism and clinical progression to dementia","volume":"90","author":"Therriault","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib94","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib95","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1002\/alz.13026","article-title":"Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer\u2019s disease","volume":"19","author":"Therriault","year":"2023","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib96","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib97","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","article-title":"Biomarker-based staging of Alzheimer disease: rationale and clinical applications","volume":"20","author":"Therriault","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib98","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1038\/s41591-025-03965-4","article-title":"Primary care detection of Alzheimer\u2019s disease using a self-administered digital cognitive test and blood biomarkers","volume":"31","author":"Tideman","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00100","article-title":"Neural Correlates of Anosognosia in Alzheimer\u2019s Disease and Mild Cognitive Impairment: A Multi-Method Assessment","volume":"12","author":"Tondelli","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1415994","article-title":"Resting-state networks and anosognosia in Alzheimer\u2019s disease","volume":"16","author":"Tondelli","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.nicl.2017.05.020","article-title":"Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging","volume":"15","author":"Vannini","year":"2017","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib102","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuropsychologia.2017.04.002","article-title":"Memory self-awareness in the preclinical and prodromal stages of Alzheimer\u2019s disease","volume":"99","author":"Vannini","year":"2017","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib103","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27472","article-title":"Trajectory of unawareness of memory decline in individuals with autosomal dominant Alzheimer disease","volume":"3","author":"Vannini","year":"2020","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib104","article-title":"Anosognosia is associated with increased prevalence and faster development of neuropsychiatric symptoms in mild cognitive impairment","volume":"16","author":"Wang","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib105","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/brain\/awae346","article-title":"A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests","volume":"148","author":"Warmenhoven","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib106","series-title":"Escala de Inteligencia Wechsler para adultos IV (Spanish version)","author":"Wechsler","year":"2012"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib107","series-title":"Wechsler memory scale-IV. Spanish edition","author":"Wechsler","year":"2013"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib108","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neurobiolaging.2022.06.007","article-title":"Metacognition, cortical thickness, and tauopathy in aging","volume":"118","author":"Zhuang","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.06.006_bib109","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hbm.26148","article-title":"Connectivity between default mode and frontoparietal networks mediates the association between global amyloid-\u03b2 and episodic memory","volume":"44","author":"Zhukovsky","year":"2023","journal-title":"Hum. Brain Mapp."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T18:59:59Z","timestamp":1786474799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458026001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":109,"alternative-id":["S0197458026001156"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.06.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased awareness of cognitive decline is associated with multimodal Alzheimer\u2019s disease biomarkers in cognitively unimpaired individuals","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}